Kits Eyecare Achieves Record Revenue and Sustained Growth in Q2 2025

Kits Eyecare ( (TSE:KITS) ) has shared an announcement.

Kits Eyecare Ltd. reported a record revenue of $49.6 million for the second quarter of 2025, marking a 31% year-over-year increase. The company also achieved its eleventh consecutive quarter of positive adjusted EBITDA, which improved to $2.6 million. This growth was driven by strong new customer acquisition and a significant increase in glasses revenue. Despite a net loss due to non-operating exchange losses, the company showed a robust operational performance with a 45.1% increase in gross profit, reflecting successful pricing and promotional strategies. Kits Eyecare is well-positioned for continued growth, with expectations of further revenue increases in the third quarter.

The most recent analyst rating on (TSE:KITS) stock is a Buy with a C$14.00 price target. To see the full list of analyst forecasts on Kits Eyecare stock, see the TSE:KITS Stock Forecast page.

Spark’s Take on TSE:KITS Stock

According to Spark, TipRanks’ AI Analyst, TSE:KITS is a Outperform.

Kits Eyecare’s overall score reflects its strong financial performance and positive outlook from the latest earnings call, despite an overvalued valuation. The stock’s bullish technical indicators are tempered by overbought signals, and corporate events support the company’s strategic direction.

To see Spark’s full report on TSE:KITS stock, click here.

More about Kits Eyecare

Kits Eyecare Ltd. is a leading vertically integrated eyecare provider, focusing on making eyecare faster, more affordable, and more accessible. The company offers a range of eyecare products, including glasses, and is committed to creating enduring value for customers, team members, and shareholders.

Average Trading Volume: 29,720

Technical Sentiment Signal: Buy

Current Market Cap: C$535.2M

See more insights into KITS stock on TipRanks’ Stock Analysis page.